Literature DB >> 7297353

DNA content and kinetic characteristics of non-Hodgkin's lymphoma: determined by flow cytometry and autoradiography.

A Costa, G Mazzini, G Del Bino, R Silvestrini.   

Abstract

The determination of DNA content and [3H]thymidine labeling index was carried out on malignant lymph nodes from 74 patients with non-Hodgkin's lymphoma. Analysis of cellular DNA content was performed using propidium iodide as DNA-specific fluorescence dye. The ploidy was expressed as the DNA ratio between the relative DNA content of the human lymphoid G0/1 cells to that of chicken red blood cells. Forty-five of the 74 non-Hodgkin's lymphomas (61%) were aneuploid populations and the majority of these (91%) showed a hyperdiploid DNA content. A higher frequency of aneuploidy (72%) was observed in tumors with unfavorable histology than in those with a favorable histology (55%). Moreover, among aneuploid lymphomas heterogeneous populations were observed in 24% of the cases. The evaluation of flow cytometric data using Fried's deconvolution procedure showed no statistically different frequency of G0/1, S and G2 + M cells between the two groups of tumors with favorable and unfavorable histology. on the contrary, a statistically different frequency of G0/1 and S cells was observed between the two groups of tumors with low and high labeling indices (P less than 0.01). A correlation was found between autoradiographic and flow cytometric determination of S phase cells (P less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7297353     DOI: 10.1002/cyto.990020310

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  14 in total

Review 1.  Proliferation indices in malignant lymphomas.

Authors:  J Crocker
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

2.  Primary mediastinal clear cell lymphoma of B-cell type.

Authors:  P Möller; B Lämmler; M Eberlein-Gonska; G E Feichter; W J Hofmann; H Schmitteckert; H F Otto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

3.  Comparison of autoradiography and DNA histograms in assessing S-phase cells from patients with myeloid leukemias.

Authors:  A Raza; A S Raza; K Kuliczkowski; S C Zhao; H D Preisler
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

4.  Effects of DTIC, DM-COOK and ICRF-159 on the number of circulating Lewis lung carcinoma cells detected by flow cytometry.

Authors:  T Giraldi; G Sava; R Cherubino; G Bottiroli; G Mazzini
Journal:  Clin Exp Metastasis       Date:  1984 Apr-Jun       Impact factor: 5.150

5.  The biology of tumor growth in the non-Hodgkin's lymphomas. A dual parameter flow cytometry study of 220 cases.

Authors:  S E Shackney; A M Levine; R I Fisher; P Nichols; E Jaffe; W H Schuette; R Simon; C A Smith; S J Occhipinti; J W Parker
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

Review 6.  Clinical and biological significance of aneuploidy in human tumours.

Authors:  M L Friedlander; D W Hedley; I W Taylor
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

7.  DNA content of T-cell lymphomas. A flow-cytometric analysis.

Authors:  D A Egerter; J W Said; S Epling; S Lee
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

8.  A comparison of static cytofluorometry and flow cytometry for the estimation of ploidy and DNA replication in human breast cancer.

Authors:  O Stål; C Klintenberg; G Franzen; B Risberg; S Arvidsson; K Bjelkenkrantz; L Skoog; B Nordenskjöld
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

9.  Prognostic importance of DNA flow cytometry in non-Hodgkin's lymphomas.

Authors:  J C Macartney; R S Camplejohn; J Alder; M G Stone; G Powell
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

10.  MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.

Authors:  A Pich; R Ponti; G Valente; L Chiusa; M Geuna; D Novero; G Palestro
Journal:  J Clin Pathol       Date:  1994-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.